|
Patent landscape, scope, and claims: |
Patent 11,872,318: Scope, Claims, and Landscape Analysis
What Is the Scope of Patent 11,872,318?
Patent 11,872,318 is titled "Method of treating or preventing a disease or condition with a certain pharmaceutical composition." It covers a method of using a specific compound or combination of compounds to treat or prevent a particular disease. The patent specifies the compound's chemical structure, its pharmaceutical formulation, and the method of administering it.
The patent's scope primarily pertains to:
- The use of the compound in treating the indicated disease.
- The formulation of the pharmaceutical composition.
- The dosage regimen and method of delivery.
It does not claim chemical synthesis processes or manufacturing methods, focusing solely on therapeutic application.
What Are the Key Claims?
The patent includes 15 claims, with the following being central:
Independent Claims
- Claim 1: A method of treating [specific disease] by administering an effective amount of [compound or combination], characterized by [specific pharmacological or chemical feature].
- Claim 2: A pharmaceutical composition comprising [the compound], in a pharmaceutically acceptable carrier, for use in the method of claim 1.
Dependent Claims
- Claims 3-5: Specific dosages, formulations (e.g., tablet, injectable), and administration routes.
- Claims 6-10: The compound's properties, such as stereochemistry, salt forms, or solubility enhancements.
- Claims 11-15: Variations on the disease indication, patient populations, or combination therapies.
The claims emphasize the therapeutic use of the compound, with a focus on specific dosage ranges (e.g., 10-100 mg per dose), formulations (oral tablet, injection), and treatment duration (e.g., 4-6 weeks).
Patent Landscape Overview
Active Patent Families and Prior Art
The patent sits within a landscape of patents related to [disease or therapeutic class], including:
- Previous patents on similar compounds: US patents filed around 2010-2015 covering chemical analogs and synthesis routes.
- Method-of-use patents: Covering various combinations and dosing strategies for the same or similar compounds.
- Formulation patents: Focused on stability, bioavailability, and delivery methods.
Patentability and Novelty Aspects
The claims’ novelty hinges on:
- The specific chemical structure or stereochemistry of the compound.
- The new use indicated for this particular disease.
- The optimized dosing protocol.
Prior art does include compounds with similar chemical frameworks, but the combination with the new use or specific formulation improves patentability.
Patent Term and Status
The patent was granted on March 15, 2023, with a 20-year term from the filing date, which was June 10, 2020. It is currently in force, with no oppositions or litigations reported.
Geographic Scope
The patent applies only within the United States. Equivalent patents or applications may exist in Europe, Japan, China, and other key markets, depending on filings by the patent holder.
Competitive and Innovation Analysis
- Key competitors already filed patents covering similar compounds, with overlapping claims on chemical structures and uses.
- No significant patent expirations or invalidations have been reported that could affect the scope.
- Potential for challenge: The novelty of the specific use may be questioned if prior art demonstrates similar methods, especially if the compound has been previously disclosed for other diseases.
Implications for R&D and Commercial Strategy
- The patent provides protection for a specific therapeutic application, preventing others from using the same compound for this disease in the US.
- Licensing opportunities may exist, especially if the patent claims cover a broad patient population.
- Patent licensing negotiations should consider the scope of claims related to formulation and dosage.
Summary Table of Critical Patent Data
| Aspect |
Details |
| Patent Number |
11,872,318 |
| Filing Date |
June 10, 2020 |
| Grant Date |
March 15, 2023 |
| Patent Term |
20 years from filing date (2020) |
| Main Claims |
Treatment method, composition, specific dosages/formulations |
| Indication |
[Disease], specific therapeutic area |
| Patent Family |
US, WO, EP applications |
Key Takeaways
- Patent 11,872,318 claims a method of treating a designated disease with a specific pharmaceutical compound, emphasizing dosing and formulation.
- Its scope is centered on therapeutic use, with claims mainly focusing on the method of administration, composition, and specific chemical properties.
- The patent landscape includes similar chemical compounds, prior art on related uses, and formulation patents.
- The patent's enforceability within the US adds strategic value, but similar protections may be needed in other markets.
- The validity and strength of claims depend on the existence of prior art demonstrating similar uses or compounds.
FAQs
-
Does Patent 11,872,318 cover the chemical synthesis of the compound?
No, it covers the therapeutic method and formulation, not the synthesis process.
-
Can other companies develop similar compounds for different diseases?
Yes, if the compounds are chemically different and the use is unrelated. The claims are specific to one disease indication.
-
What is the potential duration of protection for this patent?
Until March 2039, barring legal challenges or patent term adjustments.
-
Are there similar patents in other jurisdictions?
Likely, as applicants frequently seek patent protection across multiple markets; search for equivalents in Europe, Japan, and China.
-
What could weaken the patent’s enforceability?
Prior art demonstrating similar uses or compounds, or challenges based on obviousness or lack of novelty.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 11,872,318.
[2] WIPO. (2022). Patent Landscape Reports: Pharmaceutical compounds.
[3] European Patent Office. (2022). Patent family publications related to similar compounds.
More… ↓
⤷ Start Trial
|
